Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
11:39am, Thursday, 26'th Sep 2024
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
11:31am, Thursday, 26'th Sep 2024
Pfizer (PFE) shares declined Thursday after the drug maker recalled all lots of its sickle cell disease medicine worldwide because of concerns it could lead to severe pain and possibly death in patien
EU regulator recommends suspension of Pfizer's sickle cell disease treatment
11:13am, Thursday, 26'th Sep 2024
The European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer's sickle cell disease drug Oxbryta on Thursday.
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
10:41am, Thursday, 26'th Sep 2024
Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.
Can Pfizer Stock Rise 2x To $60?
08:00am, Thursday, 26'th Sep 2024
Pfizer stock (NYSE: PFE) is trading at about $30 per share, not far from the lows seen in recent years. Could the stock rise by over 2x in value over the next few years?
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
07:45am, Thursday, 26'th Sep 2024
Verizon and Pfizer offer attractive dividend yields above 5%, supported by strong market positions. Both companies face challenges but have strategies in place to maintain their generous payouts.
Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO
07:25am, Thursday, 26'th Sep 2024
Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the world's poorest nations at not-for-profit prices, just over two years afte
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
04:07am, Thursday, 26'th Sep 2024
W.P. Carey reduced its dividend after spinning off its office properties last year but still offers an ultra-high yield. Pfizer's been raising its dividend every year since 2009, and an unprecedented
Pfizer yanks sickle-cell treatment worldwide after possible link to deaths
05:36pm, Wednesday, 25'th Sep 2024
The benefits of Oxbryta no longer outweigh the risks, Pfizer says.
Pfizer withdraws sickle cell disease treatment from all markets
05:17pm, Wednesday, 25'th Sep 2024
U.S. drugmaker Pfizer said on Wednesday it would voluntarily withdraw its therapy Oxbryta, used for the treatment of sickle cell disease, in all markets where it is approved.
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
05:00pm, Wednesday, 25'th Sep 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
10:05am, Wednesday, 25'th Sep 2024
Pfizer and Medical Properties Trust have dividend yields well above 5%. Both companies have had their share of issues lately.
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
08:17am, Wednesday, 25'th Sep 2024
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal.
5 Blue Chip Dividend Giants Passive Income Investors Can Always Count On
02:13pm, Tuesday, 24'th Sep 2024
24/7 Wall St. Insights The futures market has priced in a 100% chance of a September rate cut.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:06am, Tuesday, 24'th Sep 2024
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
